A lower score was seen in group III than in group II, though the difference did not reach statistical significance, and the severity of arthritis was comparable to the control group ( Figure 7A ).
← all excerpts
Targeting the epitope spreader Pep19 by naïve human CD45RA<sup>+</sup> regulatory T cells dictates a distinct suppressive T cell fate in a novel form of immunotherapy.
1
—
—